{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04686",
    "Peptide Name": "Mastoparan-MO (Masto-MO, Mastoparan-L analog, Synthetic AMPs, Leu-rich, XXA, UCLL1c)",
    "Source": "Designed, motif FLPII + natural AMP",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLPIIINLKALAALAKKIL",
    "Sequence Length": 19,
    "UniProt Entry": "",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antiviral"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "6DUU",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 4,
    "Boman Index": -1.64,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "74%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (73.68%) toMastoparan-LL: 26%, I=A: 21%, K: 16%.Activity: Active against B. subtilis (to be completed). Inhibited entry of Human alphaherpesvirus 1 (HSV-1) (EC50 6.68 uM).In vitro toxicity: LC100: concentration at which cells were completely killed. Human RBC (LC100 400 uM),   murine fibroblasts L929 (LC100 >400 uM), murine macrophages monocytes RAW 264.7 (LC100 >400 uM), and human embryonic kidney HEK293 cells (LC100 25 uM).Structure:  random coil in water or POPC and helical in 50% TFE, 100 mM SDS, POPG.You can rotate, zoom, and view the NMR structureherein the PDB.In vivo toxicity:mice: no observed toxic effect till 50 mg/kg when IP injected.Animal model:mouse: To be completed.",
    "Author": "Silva ON, Torres MDT, Cao J, Alves ESF, Rodrigues LV, Resende JM, Li√£o LM, Porto WF, Fensterseifer ICM, Lu TK, Franco OL, de la Fuente-Nunez C. 2020",
    "Reference": "Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26936-26945. doi: 10.1073/pnas.2012379117.PubMed",
    "Title": "Repurposing a peptide toxin from wasp venom into antiinfectives with dual antimicrobial and immunomodulatory properties."
  },
  "3D Structure": []
}